Novo Nordisk A/S News - August 11, 2026

Novo Nordisk launches Awiqli, reducing weekly insulin injections from seven to one
NOVO-B.CO

Novo Nordisk launches Awiqli, reducing weekly insulin injections from seven to one

Novo Nordisk launched Awiqli (insulin icodec-abae) nationwide in the United States. This product is the first once-weekly basal insulin available for adults...
Novo Nordisk partners with AWS to accelerate drug discovery via London hub
NOVO-B.CO

Novo Nordisk partners with AWS to accelerate drug discovery via London hub

Novo Nordisk and Amazon Web Services (AWS) have established a strategic partnership to accelerate drug discovery using artificial intelligence and cloud...